Ifupinostat Hydrochloride for Injection Clinical Trials

1 actively recruiting trial

Also known as: BEBT-908 for Injection, CUDC-908

Pipeline

Phase 3: 1

Top Sponsors

BeBetter Med Inc1

Indications

Relapsed/Refractory Diffuse Large B-cell Lymphoma1
Cancer1

Other1 trial

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.